1. 1487PLURET: Final survival results of the phase II trial of vandetanib in patients with advanced RET-rearranged non-small cell lung cancer. (23rd October 2018) Authors: Yoh, K; Seto, T; Satouchi, M; Nishio, M; Yamamoto, N; Murakami, H; Nogami, N; Kuroda, S; Nomura, S; Sato, A; Tsuchihara, K; Kohno, T; Matsumoto, S; Goto, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1501TiPAfatinib (AFA) plus bevacizumab (BEV) combination after osimertinib (OSIME) failure for aDvanced EGFR-mutant non-small cell lung cancer (NSCLC): A multicenter prospective single arm phase II study (ABCD-study). (23rd October 2018) Authors: Hata, A; Katakami, N; Nishino, K; Mori, M; Yokoyama, T; Kurata, T; Tachihara, M; Takase, N; Daga, H; Kijima, T; Morita, S; Sakai, K; Nishio, K; Satouchi, M; Negoro, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 468PHistological type analysis of 10-year follow-up of WJTOG0105: A phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer. (24th November 2019) Authors: Tsuboi, M; Zenke, Y; Chiba, Y; Satouchi, M; Mitsuoka, S; Shimizu, J; Daga, H; Fujimoto, D; Mori, M; Aoki, T; Sawa, T; Omori, S; Saka, H; Iwamoto, Y; Okuno, M; Hirashima, T; Kashiwabara, K; Tachihara, M; Yamamoto, N; Nakagawa, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 520PA phase II study to evaluate abscopal effect by palliative radiation therapy in nivolumab treatment for pretreated non-small cell lung cancer (HANSHIN 0116). (24th November 2019) Authors: Hata, A; Satouchi, M; Morita, S; Ota, Y; Urata, Y; Kawa, Y; Okada, H; Mayahara, H; Kokubo, M; Akazawa, Y; Uenami, T; Tamiya, M; Kunimasa, K; Nakata, K; Harada, D; Nakamura, A; Takase, N; Katakami, N; Negoro, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer. (25th September 2019) Authors: Yoshioka, H; Shimokawa, M; Seto, T; Morita, S; Yatabe, Y; Okamoto, I; Tsurutani, J; Satouchi, M; Hirashima, T; Atagi, S; Shibata, K; Saito, H; Toyooka, S; Yamamoto, N; Nakagawa, K; Mitsudomi, T Journal: Annals of oncology Issue: Volume 30:Number 12(2019) Page Start: 1978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 98P Results from a phase I study of MK-1308 (anti–CTLA-4) plus pembrolizumab in previously treated advanced small cell lung cancer. (15th December 2019) Authors: Cho, B C; Yoh, K; Bar, J; Nagrial, A; Spigel, D R; Gutierrez, M; Kim, D-W; Kotasek, D; Rasco, D; Niu, J; Satouchi, M; Ahn, M-J; Lee, D H; Maurice-Dror, C; Siddiqi, S; Li, X; Cyrus, J; Altura, R A; Perets, R Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗